MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars) _ Neurodegenerative; Neuromuscular, Neuropsychiatric
Coya Therapeutics, Inc. (NASDAQ: COYA)
Organization & Developments: Coya Therapeutics
Parents
Coya Therapeutics, Inc. (NASDAQ: COYA)
Children
*Biopharma firm developing drug candidates for the treatment of various neurodegenerative and autoimmune diseases.
2024: Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off _ seekingalpha.com
2024: Coya Therapeutics: Interesting Early Data In CNS Diseases, Very Low Cash Position_ seekingalpha.com
2024: Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study
2025: An ALS treatment wave is approaching, and this biotech CEO is ready to surf
2025: Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD
2025: Coya: A Few Catalysts On The Way For COYA-302 Makes This A Must Watch
Jumps
Finance & Acquisitions: Coya Therapeutics
Key People: Coya Therapeutics